FDA tells Fresenius Medical to improve dialyzer production

FRANKFURT, March 14 Thu Mar 14, 2013 4:24am EDT

FRANKFURT, March 14 (Reuters) - Dialysis specialist Fresenius Medical Care said U.S. regulators had told it to improve the way it sterilizes certain dialyzers for filtering patients' blood.

The Food and Drug Administration (FDA) issued a warning letter to Fresenius Medical Care, saying that the process for design validation of these dialyzers, produced in Ogden, Utah, was incomplete, the German group said on Thursday.

The warning letter would not affect its sales and profit outlook for 2013 and the FDA did not impose a product recall, Fresenius added.

The dialysis company said it had confidence in the quality of the products produced in Ogden and that it would work with the FDA.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.